AIToday
Large Language ModelsAI in HealthcareASCII.jpPublished: Nov 20, 2026, 16:00 JST

AgeAI seeks clinical partners to bring voice AI to PHR and PSP

Send on LINE
AgeAI seeks clinical partners to bring voice AI to PHR and PSP

3 Key Points

  1. What happened

    AgeAI, led by CEO Gen Mikami, joined the Gotanda Valley Acceleration Program 2026 from its September 17 kickoff and is recruiting medical institutions and pharma companies as clinical proof partners.

  2. Why it matters

    The move would extend AgeAI's paid voice AI work in nursing homes into daily health records and treatment-continuation support, but the company says no trial or partnership is finalized.

  3. What to watch

    The program runs from the September 17, 2026 kickoff to Demo Day on March 19, 2027.

WHO IT HITSPharma companies running patient support programs and medical institutions interested in remote monitoring would be the likely partners, since AgeAI is asking them to co-design how conversational AI fits existing workflows.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, every morning.

Context & Analysis

AgeAI's base business is a voice conversation AI for senior care, and it has been running paid proof tests at nursing facilities and day services. That operational experience is the foundation it now wants to carry into pharma and clinical settings.

The company is framing the medical push around two concepts. PHR (personal health records) would let daily condition reports captured by phone be reviewed by the person, family, and clinicians, with possible use for monitoring elderly people living alone. PSP (patient support programs) would have the AI call patients to ask about symptoms, medication, and daily problems, and route concerns to medical staff when needed. Example settings described include adjusting questions and call frequency for a diabetes patient with drinking habits, with measurement timing following the doctor's instructions.

The Gotanda Valley Acceleration Program 2026, run by Shinagawa Ward and operated by Campus Create, selected 20 seed and early-stage companies and offers mentoring and corporate introductions. AgeAI says it will use those opportunities to shape the concept, and it is explicitly keeping expectations measured: the medical work remains at the planning stage, and details such as consent and data-sharing scope are still to be worked out with partners.

FAQ
Is AgeAI already running clinical trials?
No. AgeAI says the medical work is at the concept and study stage, and no clinical proof or partnership has been decided.
What has AgeAI already commercialized?
AgeAI is running paid proof tests of its voice conversation AI for elderly people at nursing facilities and day services.
How long is the accelerator program?
About half a year, from the September 17, 2026 kickoff to Demo Day on March 19, 2027, with 20 companies selected.
Send on LINE

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.

Questions and answers are published on this page.

Related Articles

Next articleWenge AI adds Google and Apple sign-in to ScienceOra